In The News

* Additional clinical studies are under way to evaluate the PROMETA® Treatment Program and to confirm reports from physicians using the PROMETA Treatment Program in their practices. Only a physician licensed to treat with the PROMETA Treatment Program can determine if they are appropriate for any individual patient. The medications used in the PROMETA Treatment Program are Food and Drug Administration (FDA) approved for uses other than treating dependence on alcohol, cocaine or methamphetamine. Therefore, the risks and benefits of using these medications to treat dependence on these substances have not been evaluated by the FDA.

The information provided herein is for general education purposes only and is not medical advice. Hythiam does not provide treatment or make treatment recommendations. Hythiam does not practice medicine or provide medical care to patients.

©2007 Hythiam, Inc. All rights reserved. The PROMETA Treatment Program are proprietary, patented and patent pending. Hythiam, the Hythiam logo, PROMETA, the PROMETA Treatment Program, and the PROMETA logo are trademarks of Hythiam, Inc. Hythiam does not manufacture, distribute, or sell any medications and has no relationship with any manufacturers or distributors of medications used in the PROMETA Treatment Program.